What were the primary drivers of revenue growth in this period?

Revenue growth was primarily driven by an increase in net sales across both the Retail Pharmacy and Pharmacy Benefit Management segments. Specifically, pharmacy sales growth benefited from an aging population, increased utilization of pharmaceuticals as a first line of defense, and favorable industry trends. The Front Store segment also contributed positively, supported by new store openings and a store relocation program.

How did inventory losses and product mix affect gross margins?

Gross margins improved significantly due to a reduction in inventory losses, as a result of programs initiated in 2002. Additionally, a more profitable front store product sales mix and the increasing contribution of generic drug sales, which typically have higher gross margins, also positively impacted gross margin rates.

What is the company's outlook on liquidity and future funding?

CVS Health expressed confidence in its liquidity position. They anticipate that cash flows from operations, supplemented by commercial paper and long-term borrowings, will fund business growth, capital expenditures, and debt service. The company maintained a significant credit facility and had no commercial paper outstanding as of the reporting date, indicating a strong ability to access capital if needed.

What impact did the adoption of new accounting pronouncements have?

The adoption of EITF Issue No. 02-16 resulted in a reduction in net earnings by $2.6 million for the quarter and $11.8 million for the year-to-date period. SFAS No. 150, adopted during the period, did not have a material impact on the company's financial position or results of operations.

CVS 10-Q Quarterly Report Q3 FY2003 — Revenue, Net Income, EPS

Summary

CVS Health Corporation reported a solid third quarter and first nine months of 2003, demonstrating continued growth in net sales and operating profit. Net sales increased by 8.5% for the quarter and 7.3% for the year-to-date period, driven by strong performance in both the Pharmacy and Front Store segments. The company also saw an improvement in gross margin due to decreased inventory losses and a favorable product sales mix, including the growing contribution of generic drugs which typically offer higher margins. Despite an increase in operating expenses related to advertising and employee benefits, the company managed to grow its operating profit and net earnings, with diluted EPS rising to $0.46 for the quarter and $1.42 for the year-to-date period. From a financial condition perspective, CVS Health maintained a strong liquidity position. Net cash provided by operating activities saw an increase, reflecting improved operating margins. While investing activities showed a higher net outflow primarily due to reduced sale-leaseback transactions, the company continues to invest in its real estate development program. Financing activities utilized less cash compared to the prior year, mainly due to lower commercial paper repayments. The company expressed confidence in its ability to fund its working capital needs, capital expenditures, and debt service requirements through existing cash flows and potential financing, indicating a stable outlook.

Key Highlights

1Net sales for the 13 weeks ended September 27, 2003, increased by 8.5% to $6.4 billion, and for the 39 weeks ended September 27, 2003, increased by 7.3% to $19.1 billion, compared to the prior year periods.
2Gross margin rate improved to 26.0% of net sales for the quarter (from 25.2% in Q3 2002) and 25.6% for the year-to-date period (from 25.0% in YTD 2002), attributed to decreased inventory losses and a more profitable product mix.
3Operating profit grew by 14.5% to $316.7 million for the quarter and by 13.0% to $985.0 million for the year-to-date period, indicating strong operational performance.
4Net earnings available to common shareholders increased by 14.2% to $184.1 million for the quarter and by 13.1% to $572.9 million for the year-to-date period.
5Diluted earnings per common share rose to $0.46 for the quarter and $1.42 for the year-to-date period, up from $0.40 and $1.26, respectively, in the comparable prior year periods.
6Net cash provided by operating activities increased to $756.7 million for the first nine months of 2003, up from $722.9 million in the prior year, reflecting improved operating margins.
7The company continues to expand its store base, with 4,137 stores open at the end of Q3 2003, up from 4,027 in the prior year period, supported by ongoing real estate development investments.

CVS HEALTH Corp Quarterly Report for Q3 Ended Sep 27, 2003

Summary

Key Highlights

Frequently Asked Questions